Home/Pipeline/Pain Management APIs

Pain Management APIs

Pain

CommercialActive

Key Facts

Indication

Pain

Phase

Commercial

Status

Active

Company

Noramco

About Noramco

Noramco is a globally integrated leader in the development and manufacture of controlled substance APIs, serving pharmaceutical companies in the ADHD, pain management, and addiction treatment markets. Its key strategic advantages include backward integration through its sister company Tasmanian Alkaloids, providing secure access to premium narcotic raw materials, and extensive DEA-compliant manufacturing capacity in the US and Europe. The company has recently formed the Noramco Group with Purisys and Halo Pharma to offer integrated API and drug product supply chain services, positioning itself as a critical, onshore supplier in a geopolitically sensitive sector.

View full company profile

Therapeutic Areas

Pain Management Addiction Treatment ADHD

Other Pain Drugs

Drug	Company	Phase	Status
Oxycodone Patch	Avecho Biotechnology	Preclinical	Active
Oxymorphone Patch	Avecho Biotechnology	Preclinical	Active
Desmetramadol	Syntrix Pharmaceuticals	Clinical Development	Active
Diclofenac Potassium Powder for Oral Solution	Patrin Pharma	Approved	Active
CG001419	Cullgen	Phase 1	Active
Proprietary Pain Program(s)	Oblique Therapeutics	Pre-clinical	Active
Dipendium (Diclofenac Potassium)	NovaMedica	Approved	Active
Na ion channel TicTACs	Solu Therapeutics	Preclinical	Active
Infusional Pain Management (e.g., Paracetamol)	Galenica Senese	Commercial	Active
NCEs for Pain Management	Ipca Laboratories	Preclinical/Discovery	Active
XEN1701	Xenon Pharmaceuticals	Phase 1	Clinical trial initiated